ADTX (aditxt.com) Net Profit

ADTX (aditxt.com) - company brandmark

Geopolitical tensions and reagent logistics disruptions are hindering Aditxt (ADTX) development of therapies for immune pathologies. The company's net income trend clearly confirms these challenges, with the figure recorded at 0.00. Critical capital burn and share dilution, combined with a painful transition of IT contractors, create serious risks for the business's financial stability.

ADTX (Aditxt) Net Profit history from 07/04/2022 to 07/11/2026

Analytical breakdowns and data insights for company aditxt.com (ADTX)

- price and consensus price forecast:
Stock Quotes Aditxt, Inc.|ADTX - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Aditxt, Inc.|ADTX - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Aditxt|ADTX - Book Capitalization|Market Capitalization to Book Value aditxt.com|ADTX - Aggregate Company Assets
- debt and solvency information:
Total Debt to Equity Ratio Aditxt|ADTX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Aditxt, Inc.|ADTX - Company Total Debt|Debts to Book Capitalization Aditxt, Inc.|ADTX - Company Long-Term Debt|Company Short-Term Indebtedness Aditxt|Immediate Liquidity aditxt.com
- net income and valuation multiples indicators:
ADTX - Net Profit
Summary company analysis:Aditxt
Core merchandise of Aditxt Inc.

Aditxt investments in R&D and the AditxtScore platform drive the high capital intensity of developing immune monitoring systems. The company's daily bottom line offsets quarterly reporting lags by measuring the speed of revenue generation and the business's ability to compensate for cost inflation, allowing investors to promptly assess the issuer's solvency and the risks of capital freeze within the current macroeconomic cycle.

Main competitors

Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|Intrexon - Net Profit|PHAR - Net Profit|NKTR: Net Profit|Company Profit UPB|ZBIO (Zenas Biopharma) - Net Profit|Immunome Inc (IMNM) - Net Financial Result|Net Income GOSS (Gossamer Corp)|Profit After Payment of Taxes KALV|Septerna Inc - Net Income|PVLA: Company Profit|SVRA: Net Income|Rigel Pharma - Profit After Payment of Taxes|ANAB: Net Profit|Astria Corp (ATXS) - Net Profit|ENGN (enGene Holdings Inc.) - Net Profit|Company Profit RAPT (rapt.com)|Net Income JBIO (Aerovate Therapeutics Inc)|Profit After Payment of Taxes ACRS|Kyverna - Net Income|TLSA: Company Profit|CABA - Company Net Income|Profit After Tax VTYX|THTX: Net Profit|Avalo Therapeutics, Inc. - Final Profit|ELDN (Eledon) - Net Profit|Net Profit Agenus, Inc|Company Net Income Climb Bio Inc (CLYM)|ZURA (zurabio.com) - Final Profit|Company Net Income aTyr Pharma ATYR|ADAG - Net Income|Ikena Oncology, Inc. - Net Profit|STTK - Net Profit|EQ (equilliumbio.com) - Net Income|Connect Biopharma Holdings Limited - Final Profit|IMUX (Immunic Therapeutics) - Net Profit|Atara Biotherapeutics Inc (ATRA) - Net Financial Result|Company Net Income InflaRx N.V. (IFRX)|Net Income X4 Pharmaceuticals, Inc XFOR|Company Net Income Adicet Bio, Inc. ACET|CELU - Net Income|INMB: Net Income|BRNS - Net Profit|Kezar Life Sciences, Inc (KZR) - Company Net Income|Company Profit SABS|AKTX (Akari Therapeutics) - Net Profit|Company Net Income Enlivex Therapeutics, Ltd. ENLV|Net Profit QTTB|Net Profit GeoVax Labs (GOVX)|Net Profit EDSA (Edesa)|IBIO: Company Profit|Carisma Tx - Net Profit|Net Financial Result xtlbio.com XTLB|BOLT (boltbio.com) - Net Income|HCWB: Profit After Payment of Taxes|Net Income APVO|Company Profit AIM (aimimmuno.com)|Net Income GRI (GRI Bio, Inc.)|Profit After Payment of Taxes XRTX|Net Profit HIND (Vyome Holdings)|Net Profit Revelation Biosciences Inc REVB|Indaptus - Net Profit|SCNI (BiondVax Pharmaceuticals) - Company Profit|CALI (calcimedica.com) - Net Income|AFMD: Profit After Payment of Taxes|Net Income ALLK|Company Profit HOOK (HOOKIPA)|Company Net Income IGM Biosciences, Inc. (IGMS)|ITOS: Profit After Tax|Net Profit OCEA (Ocean Biomedical, Inc.)|Final Profit TCBP|Third Harmonic Bio, Inc. - Net Profit